Showing results (2611-2620 of 2,696) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|February 2, 2023
Genomic reconstruction and directed interventions in a multidrug-resistant Shigellosis outbreak in Seattle, WA, USA: a genomic surveillance studyGiannoula S Tansarli, Dustin R Long, Adam Waalkes, et al.
The Lancet. Infectious Diseases|August 16, 2021
SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance studyRamanan Laxminarayan, Chandra Mohan B, Vinay T G, et al.
The Lancet. Infectious Diseases|August 19, 2021
Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control studyEric Yuk Fai Wan, Celine Sze Ling Chui, Francisco Tsz Tsun Lai, et al.
The Lancet. Infectious Diseases|August 13, 2022
Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trialRaburn M Mallory, Neil Formica, Susan Pfeiffer, et al.
The Lancet. Infectious Diseases|August 13, 2022
Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adultsSaskia C van der Boor, Merel J Smit, Stijn W van Beek, et al.
The Lancet. Infectious Diseases|August 14, 2022
Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort studyManish Sadarangani, Phyumar Soe, Hennady P Shulha, et al.
The Lancet. Infectious Diseases|January 11, 2026
The effectiveness of long-lasting spatial repellent emanators against malaria in humanitarian crisis settings in northern Nigeria: a two-arm pragmatic, open-label, controlled trialRichard James Allan, Ramona Scherrer, Sara Estecha-Querol, et al.
The Lancet. Infectious Diseases|November 21, 2025
National burden of and optimal vaccine policy for Japanese encephalitis virus in Bangladesh: a seroprevalence and modelling studyMariana Perez Duque, Kishor K Paul, Rebeca Sultana, et al.
The Lancet. Infectious Diseases|November 13, 2025
Post-tuberculosis lung disease: a case definition for use in research studiesGregory P Bisson, Brian Allwood, Anthony Byrne, et al.
The Lancet. Infectious Diseases|December 12, 2025
Immunogenicity and safety of a group B Streptococcus vaccine (GBS-AlpN) in pregnant women and their infants: a phase 2, multicentre, observer-blind, randomised, placebo-controlled studyPaul T Heath, Ntokozo Zuma-Gwala, Rikke Bek Helmig, et al.
Pageof 270